Ophthalmic clinical research · Danbury, ConnecticutFor sponsors & CROs
Connecticut Eye Consultants, P.C. — Ophthalmology & Clinical ResearchTalk with our team

Ophthalmic clinical research

Explore research studies.

Learn about the studies listed by our research team, then start a conversation about what may be right for you.

Ask about a study
Eye examination at Connecticut Eye Consultants

Study availability can change. These are initial criteria; the research team must confirm eligibility. No participation or treatment outcome is guaranteed.

GALLOP studyWet AMD studyDME study
Study 01 · GALLOP study

Dry age-related macular degeneration

A study for adults with dry age-related macular degeneration.

Ask about this study

Initial participation criteria

  • 60 years of age or older
  • Diagnosed with dry age-related macular degeneration
  • Willing to attend monthly study visits for 18 months
Study schedule
18 months · monthly visits
Principal investigator
Richard Scartozzi, M.D.
Sponsor
Apellis Pharmaceuticals, Inc.
Protocol
APL3007-GA-201
ClinicalTrials.gov recordView study flyer
Study 02 · Wet AMD study

Wet age-related macular degeneration

A Phase II/III study for people with wet age-related macular degeneration.

Ask about this study

Initial participation criteria

  • Diagnosed with wet age-related macular degeneration
  • No prior treatment for wet AMD in the affected eye
  • Willing to attend monthly visits over two years
Study schedule
2 years · monthly visits
Principal investigator
Richard Scartozzi, M.D.
Sponsor
EyeBiotech Limited
Protocol
MK-8748-003 (Torrontes)
ClinicalTrials.gov recordView study flyer
Study 03 · DME study

Diabetic macular edema

A Phase 3 study evaluating an investigational treatment for diabetic macular edema.

Ask about this study

Initial participation criteria

  • Type 1 or Type 2 diabetes
  • Newly diagnosed with DME, or received eye injections within the last three years
  • Decreased vision due to DME
Study schedule
Discuss the visit schedule with our team
Principal investigator
Richard Scartozzi, M.D.
Sponsor
Merck
Protocol
MK8748-005
ClinicalTrials.gov recordView study flyer

Interested in future studies?

Our research program also welcomes conversations about future opportunities. Call our team to discuss your interest.

Contact our team

Research inquiries

Questions about research?

Call 203-791-2020, extension 257, to ask about a study or our research program.

View contact details